pharma · Epilepsy · Bipolar 1 Disorder · RAPP
Rapport Therapeutics
Rapport Therapeutics patent portfolio — 1 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Boston, USA HQ
2022 Founded
94 Employees
Public company Type
RAPP · NYSE Ticker
Company details
- Status
- Public
- HQ
- Boston, USA
- Founded
- 2022
- Employees
- 94
- Programs
- 5
- Drugs
- 1
- Patents
- 1
Rapport Therapeutics patents
1 pharmaceutical patents indexed for Rapport Therapeutics. 0 expire within 24 months.
Rapport Therapeutics has 1 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
Frequently asked questions
How many patents does Rapport Therapeutics have?
1 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Rapport Therapeutics patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.